Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a ... related to the specific lesions in the pathology of NASH, including the challenges of pediatric ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

For the first time, the European Medicines Agency has recognized AI software for the diagnosis of fatty liver hepatitis as ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

The findings from the new study in The American Journal of Pathology ... progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns.

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses ... A key factor in the pathology of MASH is the disruption of endoplasmic reticulum (ER) homeostasis.